Sony Eka Nugraha
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sony Eka Nugraha has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
Rony Abdi Syahputra
4 shared publicationsJane Melita Keliat
Faculty of Vocational Study, Universitas Sumatera Utara, Medan, Indonesia
3 shared publicationsMarianne
3 shared publicationsMarianne Marianne
3 shared publications- Abdi Wira Septama
Research Center for Pharmaceutical Ingredient and Traditional Medicine, National Research and Innovation Agency (BRIN), KST Soekarno, Cibinong, Jawa Barat, 16911, Indonesia
2 shared publications Endy Juli Anto
Department of Parasitology, Faculty of Medicine, University of Methodist Indonesia, Medan, Indonesia
2 shared publications
Latest Publications
- 2 February 2026
- Published by Wiley in Cell Biology International
- Vol. 50 (2) , e70143
Brucine as a Natural Modulator of Cancer Signaling: Cellular Mechanisms, Therapeutic Potential, and Translational Perspectives
Brucine (BRU), a naturally occurring indole alkaloid primarily derived from Strychnos nux‐vomica , has recently gained attention for its notable anticancer potential. Preclinical studies using both in vitro and in vivo models have demonstrated that BRU and its semi‐synthetic derivatives exhibit significant inhibitory effects on tumor development across various cancer types, including cervical, breast, liver, skin, colon, and prostate cancers. This review explores the phytochemical properties of BRU, its chemical modifications, bioavailability, pharmacokinetics, mechanisms of anticancer activity, as well as findings from clinical research, toxicity profiles, and safety evaluations. Compared to conventional chemotherapeutic agents, BRU offers a promising alternative due to its broad‐spectrum efficacy and natural origin, although its therapeutic application is limited by a narrow safety margin. Therefore, future research should focus on the development of optimized semi‐synthetic derivatives and advanced drug delivery systems to enhance its pharmacological performance while minimizing toxicity, supporting its potential as a viable candidate in anticancer therapy.
- 2 February 2026
- Published by Wiley in Cell Biology International
- Vol. 50 (2) , e70143
Brucine as a Natural Modulator of Cancer Signaling: Cellular Mechanisms, Therapeutic Potential, and Translational Perspectives
Brucine (BRU), a naturally occurring indole alkaloid primarily derived from Strychnos nux‐vomica , has recently gained attention for its notable anticancer potential. Preclinical studies using both in vitro and in vivo models have demonstrated that BRU and its semi‐synthetic derivatives exhibit significant inhibitory effects on tumor development across various cancer types, including cervical, breast, liver, skin, colon, and prostate cancers. This review explores the phytochemical properties of BRU, its chemical modifications, bioavailability, pharmacokinetics, mechanisms of anticancer activity, as well as findings from clinical research, toxicity profiles, and safety evaluations. Compared to conventional chemotherapeutic agents, BRU offers a promising alternative due to its broad‐spectrum efficacy and natural origin, although its therapeutic application is limited by a narrow safety margin. Therefore, future research should focus on the development of optimized semi‐synthetic derivatives and advanced drug delivery systems to enhance its pharmacological performance while minimizing toxicity, supporting its potential as a viable candidate in anticancer therapy.
- Open Access
- 7 July 2025
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
- p. 435-443
FORMULATION OF ANTI-DIABETIC ULCER GEL ENRICHED WITH ALOE VERA EXTRACT AND FISH COLLAGEN: AN IN VIVO STUDY
Objective: Diabetic ulcers are a common complication of diabetes mellitus, with a significantly increased risk of infection, delayed healing, and potential limb amputation. This study aimed to develop and evaluate a novel anti-diabetic ulcer gel containing Aloe vera extract and fish collagen, focusing on its formulation, stability, and wound healing efficacy in a diabetic rat model. Methods: Aloe vera extract and fish collagen were extracted and characterized using Fourier Transform Infrared Spectroscopy (FTIR) for collagen verification and antioxidant testing for Aloe vera. Three different gel formulations (F1, F2, F3) were prepared and assessed for homogeneity, pH, viscosity, and stability over 12 w at varying temperatures. The in vivo study was conducted using streptozotocin (STZ)-induced diabetic rats to evaluate wound healing efficacy, with wound size reduction, histopathological analysis (fibroblast proliferation and collagen density), and statistical comparisons performed using Analysis of Variance (ANOVA) with GraphPad Prism 9. Results: Aloe vera extract demonstrated strong antioxidant properties, with an half-maximal inhibitory concentration IC50 value of 39.976 μg/ml. Fish collagen met standard collagen characteristics based on FTIR analysis, confirming its structural integrity. The gel formulations remained stable over 12 w, maintaining homogeneity, pH, and viscosity within acceptable ranges. In vivo experiments showed that rats treated with Formula F2 (Group 4) exhibited the highest wound healing rate, achieving 100% wound closure by day 12. Fibroblast proliferation and collagen deposition were significantly higher in the F2-treated group compared to control groups (p<0.05). Histopathological analysis confirmed enhanced tissue regeneration and reduced inflammation, demonstrating the gel’s effectiveness in accelerating diabetic wound healing. Conclusion: The combination of Aloe vera and fish collagen in a gel formulation effectively accelerates diabetic wound healing, demonstrating antioxidant, anti-inflammatory, and tissue-regenerative properties.
- 7 July 2025
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
- p. 435-443
Open AccessFORMULATION OF ANTI-DIABETIC ULCER GEL ENRICHED WITH ALOE VERA EXTRACT AND FISH COLLAGEN: AN IN VIVO STUDY
Objective: Diabetic ulcers are a common complication of diabetes mellitus, with a significantly increased risk of infection, delayed healing, and potential limb amputation. This study aimed to develop and evaluate a novel anti-diabetic ulcer gel containing Aloe vera extract and fish collagen, focusing on its formulation, stability, and wound healing efficacy in a diabetic rat model. Methods: Aloe vera extract and fish collagen were extracted and characterized using Fourier Transform Infrared Spectroscopy (FTIR) for collagen verification and antioxidant testing for Aloe vera. Three different gel formulations (F1, F2, F3) were prepared and assessed for homogeneity, pH, viscosity, and stability over 12 w at varying temperatures. The in vivo study was conducted using streptozotocin (STZ)-induced diabetic rats to evaluate wound healing efficacy, with wound size reduction, histopathological analysis (fibroblast proliferation and collagen density), and statistical comparisons performed using Analysis of Variance (ANOVA) with GraphPad Prism 9. Results: Aloe vera extract demonstrated strong antioxidant properties, with an half-maximal inhibitory concentration IC50 value of 39.976 μg/ml. Fish collagen met standard collagen characteristics based on FTIR analysis, confirming its structural integrity. The gel formulations remained stable over 12 w, maintaining homogeneity, pH, and viscosity within acceptable ranges. In vivo experiments showed that rats treated with Formula F2 (Group 4) exhibited the highest wound healing rate, achieving 100% wound closure by day 12. Fibroblast proliferation and collagen deposition were significantly higher in the F2-treated group compared to control groups (p<0.05). Histopathological analysis confirmed enhanced tissue regeneration and reduced inflammation, demonstrating the gel’s effectiveness in accelerating diabetic wound healing. Conclusion: The combination of Aloe vera and fish collagen in a gel formulation effectively accelerates diabetic wound healing, demonstrating antioxidant, anti-inflammatory, and tissue-regenerative properties.
- Open Access
- 1 June 2025
- Published by An-Najah National University in Palestinian Medical and Pharmaceutical Journal
- Vol. 11 (3) , 241-248
Exploring Antioxidant, Antibacterial, and Toxicity Prediction of Purslane Herb (Portulaca oleracea L.) from Several Extraction Solvents
In traditional herbal medicine, Indonesians generally use the purslane plant as an ingredient. This research aims to determine the antioxidant capacity and antibacterial properties of purslane plants using different solvents. The research methodology involved extracting purslane using different solvents, such as methanol, herbal ethyl, acetate, and hexane. Antioxidant testing used the DPPH method and compared the results with those obtained from vitamin C. This experiment employed the phytochemical diffusion method. Variations in solvent polarity may explain the differences between the results of phytochemical screening tests for various fractions and the results obtained from in silico toxicity tests using the Protox II and PKCsm methods. IC50 methanol fraction had an antioxidant activity of 96.12 ± 0.02, the ethyl acetate fraction 56.78 ± 0.04, the N-hexane fraction 456.72 ± 0.467, and Vitamin C 10.67 ± 0.02. The most effective against E. Colli is the ethyl acetate fraction with an inhibition zone value of 14.00 ± 0.10. Against Pseudomonas aeruginosa the ethyl acetate fraction was 17.77 ± 0.15, against Salmonella typi the N – Hexane fraction 15.24 ± 0.71, against Bacillus subtilis ethyl acetate fraction 14.77 ± 0.01, against Streptococcus pneumonia the N – fraction Hexane 14.08 ± 0.36 and against Streptococcus aureus ethyl acetate fraction 16.77 ± 0.17. The in silico toxicity prediction results classified the lutein component as a highly toxic component. However, not all purslane components show hepatotoxicity. Conclusion: The study found that the purslane herb fraction showed antioxidant properties, inhibited the growth of gram-negative and gram-positive bacteria, did not show hepatotoxicity, and had significant toxicity to the lutein component.
- 1 June 2025
- Published by An-Najah National University in Palestinian Medical and Pharmaceutical Journal
- Vol. 11 (3) , 241-248
Open AccessExploring Antioxidant, Antibacterial, and Toxicity Prediction of Purslane Herb (Portulaca oleracea L.) from Several Extraction Solvents
In traditional herbal medicine, Indonesians generally use the purslane plant as an ingredient. This research aims to determine the antioxidant capacity and antibacterial properties of purslane plants using different solvents. The research methodology involved extracting purslane using different solvents, such as methanol, herbal ethyl, acetate, and hexane. Antioxidant testing used the DPPH method and compared the results with those obtained from vitamin C. This experiment employed the phytochemical diffusion method. Variations in solvent polarity may explain the differences between the results of phytochemical screening tests for various fractions and the results obtained from in silico toxicity tests using the Protox II and PKCsm methods. IC50 methanol fraction had an antioxidant activity of 96.12 ± 0.02, the ethyl acetate fraction 56.78 ± 0.04, the N-hexane fraction 456.72 ± 0.467, and Vitamin C 10.67 ± 0.02. The most effective against E. Colli is the ethyl acetate fraction with an inhibition zone value of 14.00 ± 0.10. Against Pseudomonas aeruginosa the ethyl acetate fraction was 17.77 ± 0.15, against Salmonella typi the N – Hexane fraction 15.24 ± 0.71, against Bacillus subtilis ethyl acetate fraction 14.77 ± 0.01, against Streptococcus pneumonia the N – fraction Hexane 14.08 ± 0.36 and against Streptococcus aureus ethyl acetate fraction 16.77 ± 0.17. The in silico toxicity prediction results classified the lutein component as a highly toxic component. However, not all purslane components show hepatotoxicity. Conclusion: The study found that the purslane herb fraction showed antioxidant properties, inhibited the growth of gram-negative and gram-positive bacteria, did not show hepatotoxicity, and had significant toxicity to the lutein component.
- Open Access
- 9 December 2024
- Published by Pensoft Publishers in Pharmacia
- Vol. 71, 1-15
Unveiling the anticancer potential of the ethanolic extract from Pometia pinnata: Molecular dynamics targeting CHK1 and cytotoxicity study on MCF-7 cells
Cancer remains one of the most lethal diseases globally, with CHK1 being a critical pathway frequently altered in cancer progression. This study evaluated the anticancer and cytotoxic properties of the ethanol extract of Matoa (Pometia pinnata) leaves in silico and in vitro. Maceration was conducted to obtain the ethanol extract with physicochemical, pharmacokinetic, and toxicity predictions conducted using Lipinski’s Rule of Five, pkCSM, and Pro-Tox II. Molecular docking was performed using Autodock Vina and DOCK6.2, followed by molecular dynamic simulations using GROMACS. Cytotoxicity assays on MCF-7 cells were carried out using the MTT methods. The results demonstrated that the extract tested positive for flavonoids, alkaloids, tannins, saponins, glycosides, and steroids. The extract also shows potential inhibitory activity against CHK1, supported by favorable binding affinities and critical amino acid interactions. Additionally, the extract exhibited a moderate cytotoxic effect on cell MCF-7 with an IC50 of 139 µg/mL.
- 9 December 2024
- Published by Pensoft Publishers in Pharmacia
- Vol. 71, 1-15
Open AccessUnveiling the anticancer potential of the ethanolic extract from Pometia pinnata: Molecular dynamics targeting CHK1 and cytotoxicity study on MCF-7 cells
Cancer remains one of the most lethal diseases globally, with CHK1 being a critical pathway frequently altered in cancer progression. This study evaluated the anticancer and cytotoxic properties of the ethanol extract of Matoa (Pometia pinnata) leaves in silico and in vitro. Maceration was conducted to obtain the ethanol extract with physicochemical, pharmacokinetic, and toxicity predictions conducted using Lipinski’s Rule of Five, pkCSM, and Pro-Tox II. Molecular docking was performed using Autodock Vina and DOCK6.2, followed by molecular dynamic simulations using GROMACS. Cytotoxicity assays on MCF-7 cells were carried out using the MTT methods. The results demonstrated that the extract tested positive for flavonoids, alkaloids, tannins, saponins, glycosides, and steroids. The extract also shows potential inhibitory activity against CHK1, supported by favorable binding affinities and critical amino acid interactions. Additionally, the extract exhibited a moderate cytotoxic effect on cell MCF-7 with an IC50 of 139 µg/mL.
- Open Access
- 27 May 2024
- Published by ResearchersLinks Ltd in Advances in Animal and Veterinary Sciences
- Vol. 12 (7)
Efficacy of Carica papaya Leaves Extract for Treating Thrombocytopenia: An In Silico and In Vivo Study in Rat Model
| The aim of this study was to determine the anti-thrombocytopenic activity of the ethanol extract of C. papaya leaves in rats using in silico and in vivo studies. Analysis of phytochemical compounds was carried out using GCMS and qualitative phytochemical screening. Additionally, antioxidant activity was determined by spectrophotometry. A rat model of thrombocytopenia was established by subcutaneous injection of heparin at 2000 IU/kg body weight (BW) for 10 days. After induction, rats were administered C. papaya leaves ethanol extract at various concentrations (50, 100, and 200 mg/kg BW) for 20 days. On day 21, the duke method was used to examine the bleeding time, and the blood clotting time was evaluated using the Lee White method. Blood samples were evaluated for platelet concentration, thrombopoietin concentration, prothrombin time, and active partial thromboplastin time. These results indicated that the C. papaya leaf extract contained various compounds. ABTS antioxidant activity assay showed an IC50 of 45.50 μg/ml. In vivo examination revealed that C. papaya extract has potential anti-thrombocytopenic effects; doses of 100 and 200 mg/kg BW showed significant improvement in the hematology profile from that of the heparin control (p < 0.05). In particular, doses of 200 mg/kg BW have the best potential for the development of anti-thrombocytopenic agents. Furthermore, an in silico study found that the main compound of C. papaya interacts with multiple amino acid residues, indicating stable binding affinity. Finally, it can be concluded that C. papaya has potential as an anti-thrombocytopenic agent.
- 27 May 2024
- Published by ResearchersLinks Ltd in Advances in Animal and Veterinary Sciences
- Vol. 12 (7)
Open AccessEfficacy of Carica papaya Leaves Extract for Treating Thrombocytopenia: An In Silico and In Vivo Study in Rat Model
| The aim of this study was to determine the anti-thrombocytopenic activity of the ethanol extract of C. papaya leaves in rats using in silico and in vivo studies. Analysis of phytochemical compounds was carried out using GCMS and qualitative phytochemical screening. Additionally, antioxidant activity was determined by spectrophotometry. A rat model of thrombocytopenia was established by subcutaneous injection of heparin at 2000 IU/kg body weight (BW) for 10 days. After induction, rats were administered C. papaya leaves ethanol extract at various concentrations (50, 100, and 200 mg/kg BW) for 20 days. On day 21, the duke method was used to examine the bleeding time, and the blood clotting time was evaluated using the Lee White method. Blood samples were evaluated for platelet concentration, thrombopoietin concentration, prothrombin time, and active partial thromboplastin time. These results indicated that the C. papaya leaf extract contained various compounds. ABTS antioxidant activity assay showed an IC50 of 45.50 μg/ml. In vivo examination revealed that C. papaya extract has potential anti-thrombocytopenic effects; doses of 100 and 200 mg/kg BW showed significant improvement in the hematology profile from that of the heparin control (p < 0.05). In particular, doses of 200 mg/kg BW have the best potential for the development of anti-thrombocytopenic agents. Furthermore, an in silico study found that the main compound of C. papaya interacts with multiple amino acid residues, indicating stable binding affinity. Finally, it can be concluded that C. papaya has potential as an anti-thrombocytopenic agent.
- Open Access
- 25 April 2024
- Published by Medic Scientific in Journal of Medical pharmaceutical and allied sciences
- Vol. 13 (2) , 6464-6471
Exploring the potential of Beta Vulgaris L. Against thrombocytopenia: in vitro, in silico, phytochemicals, and antioxidant analysis
The purpose of this study was to assess anti- thrombocytopenia of beetroot extract using both in vitro and in silico methods. Additionally, antioxidant capacity, phenolic content, and flavonoid content of beetroot were determined. The extraction procedure was optimized by reflux method, the extracts obtained were examined to determine the Total Phenolic Content (TPC) and Total Flavonoid Content (TFC) using the Folin-Ciocalteu colorimetric and aluminum chloride methods, respectively. Furthermore, antioxidant capacity was assessed using the DPPH method, while betanin concentration was determined by thin-layer chromatography. This research approach encompasses the binding acticity of ligands and target proteins, the process of docking thrombopoietin receptor (TPOr) and betanin compound using Swissdock, and the examination of docking data using the USCF Chimera software. The studies revealed that the reflux-extracted beetroot extract had a total phenol concentration of 39.72 ± 2.56 mgGAE/g. The flavonoid concentration of beetroot extract obtained using reflux extraction was 5.47 ±…
- 25 April 2024
- Published by Medic Scientific in Journal of Medical pharmaceutical and allied sciences
- Vol. 13 (2) , 6464-6471
Open AccessExploring the potential of Beta Vulgaris L. Against thrombocytopenia: in vitro, in silico, phytochemicals, and antioxidant analysis
The purpose of this study was to assess anti- thrombocytopenia of beetroot extract using both in vitro and in silico methods. Additionally, antioxidant capacity, phenolic content, and flavonoid content of beetroot were determined. The extraction procedure was optimized by reflux method, the extracts obtained were examined to determine the Total Phenolic Content (TPC) and Total Flavonoid Content (TFC) using the Folin-Ciocalteu colorimetric and aluminum chloride methods, respectively. Furthermore, antioxidant capacity was assessed using the DPPH method, while betanin concentration was determined by thin-layer chromatography. This research approach encompasses the binding acticity of ligands and target proteins, the process of docking thrombopoietin receptor (TPOr) and betanin compound using Swissdock, and the examination of docking data using the USCF Chimera software. The studies revealed that the reflux-extracted beetroot extract had a total phenol concentration of 39.72 ± 2.56 mgGAE/g. The flavonoid concentration of beetroot extract obtained using reflux extraction was 5.47 ±…
- Open Access
- 29 February 2024
- Published by Medic Scientific in Journal of Medical pharmaceutical and allied sciences
- Vol. 13 (1) , 6285-6291
Assessing the toxicity and anti-anemia of Beta Vulgaris L.: in silico, phytochemical and antioxidant analysis
The objective of this investigation was to determine the toxicity, anti-anemia activity, betanin content, flavonoid content, and antioxidant capacity of Beta vulgaris L. Microwave-assisted extraction (MAE) was implemented to optimize the extraction procedure. The total phenolic content (TPC) and total flavonoid content (TFC) of the extracts were determined using the Folin-Ciocalteu colorimetric and aluminum chloride methods, respectively. Furthermore, the 2,2-diphenyl-1-picrylhydrazyl (DPPH) method was employed to ascertain antioxidant capacity, whereas thin-layer chromatography was used to identify betanin content. The toxicity and anti-anemia properties were assessed in silico. The in-silico methods encompass several steps: ligand and target protein synthesis, docking of betanin compounds with the erythropoietin receptor (EpoR) target protein via SwissDock, docking data visualization via USCF Chimera, and toxicity analysis via the pkCSM and Protox online tools.The findings indicated that the beetroot extract contained a total of 34.96 ± 3.97 mg GAE/g sample of phenol. The flavonoid content of beetroot was…
- 29 February 2024
- Published by Medic Scientific in Journal of Medical pharmaceutical and allied sciences
- Vol. 13 (1) , 6285-6291
Open AccessAssessing the toxicity and anti-anemia of Beta Vulgaris L.: in silico, phytochemical and antioxidant analysis
The objective of this investigation was to determine the toxicity, anti-anemia activity, betanin content, flavonoid content, and antioxidant capacity of Beta vulgaris L. Microwave-assisted extraction (MAE) was implemented to optimize the extraction procedure. The total phenolic content (TPC) and total flavonoid content (TFC) of the extracts were determined using the Folin-Ciocalteu colorimetric and aluminum chloride methods, respectively. Furthermore, the 2,2-diphenyl-1-picrylhydrazyl (DPPH) method was employed to ascertain antioxidant capacity, whereas thin-layer chromatography was used to identify betanin content. The toxicity and anti-anemia properties were assessed in silico. The in-silico methods encompass several steps: ligand and target protein synthesis, docking of betanin compounds with the erythropoietin receptor (EpoR) target protein via SwissDock, docking data visualization via USCF Chimera, and toxicity analysis via the pkCSM and Protox online tools.The findings indicated that the beetroot extract contained a total of 34.96 ± 3.97 mg GAE/g sample of phenol. The flavonoid content of beetroot was…
- Open Access
- 7 January 2024
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
- p. 118-123
INVESTIGATING THE TOXICITY OF BETALAIN COMPOUNDS: IN SILICO ANALYSIS AND IN VIVO PREDICTIONS FOR STANDARDIZED BETA VULGARIS L. EXTRACT
Objective: Extensive research has been conducted on beetroot's antioxidant, hematoprotective, and cardioprotective properties. However, there currently needs to be more available evidence pertaining to the toxicity assessment of the extract. The toxicity assessment was conducted using both in silico and in vivo methods. Prior to testing, the extracts were standardized in accordance with the guidelines set by the Indonesian Food Drug Authority (BPOM), which is the regulatory authority for food and drugs in Indonesia. Methods: The experimental subjects consisted of 25 male Wistar rats in good health, weighing between 150 and 170 grams. These rats were separated into five groups, each including five rats. Group 1 will serve as the control group, while groups 2 through 5 will be designated as the treatment groups. The analysis of chemical toxicity was conducted using pK-CSM, SwissADME, and Pro-Tox II methodologies. Results: The results indicated that the standardized ethanol extract contained 4.341% water, 3.67 % total ash, and 1.53 % acid-insoluble ash. Lead (Pb) and cadmium (Cd) were absent at a concentration of 0 parts per million (ppm). Subsequently, the total plate count and yeast mould count were 0.47 5 x 10-4 (CFU/g) and a of 0.382 x 10-4 (CFU/g) respectively. This finding implies that the extract meets BPOM requirement. This study also measured the betalain content of red beetroot, yielding a total concentration of 11.34 0.37 mg/100 gram of sample. Haematological experiments showed that beetroot extract affected rat blood haematology. Compared to the control group, rats given the extract had higher red blood cell and platelet counts. Additionally, the Insilico toxicity test conducted on the active component derived from beetroot revealed LD50 of the compounds ranged from 305 mg/kg so that were categorized into classes IV and presence of hepatotoxic potential. During the in vivo experiment, there has been a notable rise in hepatic and renal parameters. Furthermore, one mortality event occurred in the test subject at a 5,000 mg/kg body weight dosage. Conclusion: Single oral administration of the extract at a dose larger than 5,000 mg per kilogram of body weight does not result in lethal effects, however showed potential toxicity to the liver.
- 7 January 2024
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
- p. 118-123
Open AccessINVESTIGATING THE TOXICITY OF BETALAIN COMPOUNDS: IN SILICO ANALYSIS AND IN VIVO PREDICTIONS FOR STANDARDIZED BETA VULGARIS L. EXTRACT
Objective: Extensive research has been conducted on beetroot's antioxidant, hematoprotective, and cardioprotective properties. However, there currently needs to be more available evidence pertaining to the toxicity assessment of the extract. The toxicity assessment was conducted using both in silico and in vivo methods. Prior to testing, the extracts were standardized in accordance with the guidelines set by the Indonesian Food Drug Authority (BPOM), which is the regulatory authority for food and drugs in Indonesia. Methods: The experimental subjects consisted of 25 male Wistar rats in good health, weighing between 150 and 170 grams. These rats were separated into five groups, each including five rats. Group 1 will serve as the control group, while groups 2 through 5 will be designated as the treatment groups. The analysis of chemical toxicity was conducted using pK-CSM, SwissADME, and Pro-Tox II methodologies. Results: The results indicated that the standardized ethanol extract contained 4.341% water, 3.67 % total ash, and 1.53 % acid-insoluble ash. Lead (Pb) and cadmium (Cd) were absent at a concentration of 0 parts per million (ppm). Subsequently, the total plate count and yeast mould count were 0.47 5 x 10-4 (CFU/g) and a of 0.382 x 10-4 (CFU/g) respectively. This finding implies that the extract meets BPOM requirement. This study also measured the betalain content of red beetroot, yielding a total concentration of 11.34 0.37 mg/100 gram of sample. Haematological experiments showed that beetroot extract affected rat blood haematology. Compared to the control group, rats given the extract had higher red blood cell and platelet counts. Additionally, the Insilico toxicity test conducted on the active component derived from beetroot revealed LD50 of the compounds ranged from 305 mg/kg so that were categorized into classes IV and presence of hepatotoxic potential. During the in vivo experiment, there has been a notable rise in hepatic and renal parameters. Furthermore, one mortality event occurred in the test subject at a 5,000 mg/kg body weight dosage. Conclusion: Single oral administration of the extract at a dose larger than 5,000 mg per kilogram of body weight does not result in lethal effects, however showed potential toxicity to the liver.
- Open Access
- 1 January 2024
- Published by Maad Rayan Publishing Company in Journal of Herbmed Pharmacology
- Vol. 13 (1) , 153-162
Antibacterial, bacteriolytic, antibiofilm, and synergistic effects of Curcuma species ethanol extracts with antibiotic against multidrug resistant Pseudomonas aeruginosa
Introduction: Curcuma species have shown antibacterial activity against Pseudomonas aeruginosa. The current study was conducted to analyze the antibacterial activity of ethanol extracts of Curcuma species rhizomes, including Curcuma domestica, C. xanthorrhiza, C. mangga, C. zedoaria, and C. aeruginosa against multidrug-resistant Pseudomonas aeruginosa (MDR P. aeruginosa). Furthermore, the mechanism action of Curcuma species in combination with antibiotic against MDR P. aeruginosa and its chemical component were also investigated. Methods: Determination of minimum inhibitory concentration (MIC) was carried out by the microdilution method. The synergistic effects of the extract and tetracycline were determined by the checkerboard method. The effect of the combination of Curcuma species and tetracycline to prevent bacterial resistance was investigated using inhibition of biofilm formation, permeability of bacterial cell membrane, and EtBr accumulation methods. Gas chromatography-mass spectrometry (GC-MS) analysis was also performed. Results: MIC of C. domestica, C. xanthorrhiza, and C. mangga against MDR P. aeruginosa were 125, 250, and 125 µg/mL, respectively. C. xanthorrhiza ethanol extract (7.8 µg/mL) in combination with tetracycline (1.9 µg/mL) revealed a synergistic activity with Fractional Inhibitory Concentration Index (FICI) value of 0.06. The combination of C. xanthorrhiza ethanol extract and tetracycline showed inhibitory effects on biofilm formation and efflux pump of MDR P. aeruginosa. This combination also had bacteriolytic activity. GC-MS analysis led to the identification of ar-turmerone (11.63%) and xanthorrhizol (11.36%) as the major compounds. Conclusion: Combination of C. xanthorrhiza ethanol extract and tetracycline might be developed as an alternative treatment against MDR P. aeruginosa.
- 1 January 2024
- Published by Maad Rayan Publishing Company in Journal of Herbmed Pharmacology
- Vol. 13 (1) , 153-162
Open AccessAntibacterial, bacteriolytic, antibiofilm, and synergistic effects of Curcuma species ethanol extracts with antibiotic against multidrug resistant Pseudomonas aeruginosa
Introduction: Curcuma species have shown antibacterial activity against Pseudomonas aeruginosa. The current study was conducted to analyze the antibacterial activity of ethanol extracts of Curcuma species rhizomes, including Curcuma domestica, C. xanthorrhiza, C. mangga, C. zedoaria, and C. aeruginosa against multidrug-resistant Pseudomonas aeruginosa (MDR P. aeruginosa). Furthermore, the mechanism action of Curcuma species in combination with antibiotic against MDR P. aeruginosa and its chemical component were also investigated. Methods: Determination of minimum inhibitory concentration (MIC) was carried out by the microdilution method. The synergistic effects of the extract and tetracycline were determined by the checkerboard method. The effect of the combination of Curcuma species and tetracycline to prevent bacterial resistance was investigated using inhibition of biofilm formation, permeability of bacterial cell membrane, and EtBr accumulation methods. Gas chromatography-mass spectrometry (GC-MS) analysis was also performed. Results: MIC of C. domestica, C. xanthorrhiza, and C. mangga against MDR P. aeruginosa were 125, 250, and 125 µg/mL, respectively. C. xanthorrhiza ethanol extract (7.8 µg/mL) in combination with tetracycline (1.9 µg/mL) revealed a synergistic activity with Fractional Inhibitory Concentration Index (FICI) value of 0.06. The combination of C. xanthorrhiza ethanol extract and tetracycline showed inhibitory effects on biofilm formation and efflux pump of MDR P. aeruginosa. This combination also had bacteriolytic activity. GC-MS analysis led to the identification of ar-turmerone (11.63%) and xanthorrhizol (11.36%) as the major compounds. Conclusion: Combination of C. xanthorrhiza ethanol extract and tetracycline might be developed as an alternative treatment against MDR P. aeruginosa.
- Open Access
- 7 November 2023
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
- p. 172-177
FORMULATION AND EVALUATION OF HERBAL CAPSULE CONTAINING CURCUMA MANGGA VALETON and ZIJP. EXTRACT AND ITS IMMUNOSTIMULATORY EFFECTS
Objective: The present study was carried out to formulate and evaluate C. mangga extract as granule mass in a capsule dosage form as well as investigate its immunostimulatory effects. Methods: The granule mass was evaluated for its bulk density, tapped density, Carr’s index, Hausner ratio, angle of repose, and flow ability. Meanwhile, capsule weight and disintegration time were determined to evaluate the C. mangga capsule. The immunostimulatory effects of extract in capsule dosage form were investigated by measuring delayed-type hypersensitivity (DTH) response and IgG production. There were six formula prepared (F1-F6). Formula F1-F6 were vary according to the component of adsorbent (Corn starch/polyvinyl pyrrolidone) and filler (maltodextrin/Avicel/lactose) to obtain the optimum formula. Results: The granule mass of all formula had a good flow ability and free-flowing properties according to the Carr’s index (10.26±3.38 to 17.54±1.60) and flowing time (1.05±0.05 to 1.60±0.08 seconds). Of all the capsule formula, F2 capsule containing dry extract of C. mangga with Avicel as the filler met the standard requirement in terms of disintegration time (2.15±0.76 min) and weight uniformity (the deviation was below than 7.5%). The capsule of C. mangga extract enhanced the paw thickness as compared to those of the negative control (P<0.05). The level of Immunoglobulin G (IgG) was also increased after treatment with the capsule of C. mangga extract. Conclusion: The results suggest that the capsule of C. mangga extract has immunostimulatory effects, emphasizing its potential to be used for the treatment of infectious and immunodeficiency diseases.
- 7 November 2023
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
- p. 172-177
Open AccessFORMULATION AND EVALUATION OF HERBAL CAPSULE CONTAINING CURCUMA MANGGA VALETON and ZIJP. EXTRACT AND ITS IMMUNOSTIMULATORY EFFECTS
Objective: The present study was carried out to formulate and evaluate C. mangga extract as granule mass in a capsule dosage form as well as investigate its immunostimulatory effects. Methods: The granule mass was evaluated for its bulk density, tapped density, Carr’s index, Hausner ratio, angle of repose, and flow ability. Meanwhile, capsule weight and disintegration time were determined to evaluate the C. mangga capsule. The immunostimulatory effects of extract in capsule dosage form were investigated by measuring delayed-type hypersensitivity (DTH) response and IgG production. There were six formula prepared (F1-F6). Formula F1-F6 were vary according to the component of adsorbent (Corn starch/polyvinyl pyrrolidone) and filler (maltodextrin/Avicel/lactose) to obtain the optimum formula. Results: The granule mass of all formula had a good flow ability and free-flowing properties according to the Carr’s index (10.26±3.38 to 17.54±1.60) and flowing time (1.05±0.05 to 1.60±0.08 seconds). Of all the capsule formula, F2 capsule containing dry extract of C. mangga with Avicel as the filler met the standard requirement in terms of disintegration time (2.15±0.76 min) and weight uniformity (the deviation was below than 7.5%). The capsule of C. mangga extract enhanced the paw thickness as compared to those of the negative control (P<0.05). The level of Immunoglobulin G (IgG) was also increased after treatment with the capsule of C. mangga extract. Conclusion: The results suggest that the capsule of C. mangga extract has immunostimulatory effects, emphasizing its potential to be used for the treatment of infectious and immunodeficiency diseases.